UNI-BIO GROUP (00690) recommends terminating the current stock purchase plan and adopting a new stock purchase plan.
Liankang Biotechnology Group (00690) has announced that the board of directors has proposed to (i) terminate the existing share purchase plan; and (ii) adopt a new share purchase plan for shareholders' approval.
The UNI-BIO GROUP (00690) has announced that the Board of Directors has recommended (i) terminating the existing share purchase plan; and (ii) adopting a new share purchase plan for shareholder approval.
Related Articles
LIVZON PHARMA's first-quarter net profit attributable to its parent company was RMB 577 million, a year-on-year decrease of 9.39%.
US Stock Market Move | Q2 performance guidance is strong, Texas Instruments Incorporated (TXN.US) surged nearly 15% to hit a new all-time high.
On April 23, the Green Tea Group (06831) spent 1.027 million Hong Kong dollars to repurchase 12.84 thousand shares.
LIVZON PHARMA's first-quarter net profit attributable to its parent company was RMB 577 million, a year-on-year decrease of 9.39%.
US Stock Market Move | Q2 performance guidance is strong, Texas Instruments Incorporated (TXN.US) surged nearly 15% to hit a new all-time high.
On April 23, the Green Tea Group (06831) spent 1.027 million Hong Kong dollars to repurchase 12.84 thousand shares.
RECOMMEND
The Great Transformation Of The Hong Kong Automotive Market
23/04/2026
Another “Elephant” Dances As China Construction Bank Hits A Record High While The Sector Remains Below Book Value, With Several Names Offering Elevated Dividend Yields
23/04/2026
Major Oil Traders Warn One Billion Barrel Shortfall Is Locked In, Hormuz Closure Could Trigger Recession
23/04/2026
